Macchiarini May Face Involuntary Manslaughter Charges

The embattled stem cell researcher faces a new investigation exploring his culpability in the deaths of two patients he treated.

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

PIXABAY, DEBORABALVESThe artificial organ researcher who was fired from Sweden’s Karolinska Institute earlier this year has been charged with involuntary manslaughter for the deaths of two of his patients, upon whom he performed artificial trachea transplants, according to Swedish prosecutors. After years of ethical inquiries into his research and clinical practice, Paolo Macchiarini was informed last week of the criminal investigation that may end in formal charges of involuntary manslaughter. The investigation will likely center on two patients Macchiarini treated in the U.S.: one a 2-year-old girl who died in 2013, several months after the procedure; the other, an adult male in Baltimore, who died in 2011, three months after his surgery.

“Of course with the accusations that were made against me last year the prosecutor has to investigate, and I have been very happy to give them any information that they need for that investigation,” Macchiarini told the Associated Press in an email.

If Macchiarini is charged with aggravated involuntary manslaughter, he could face between six months and six years in prison.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies